Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-2025-04-21

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Cadisegliatin

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    vTv Therapeutics: FDA Lifts Clinical Hold on Cadisegliatin Program
    vTv Therapeutics: FDA Lifts Clinical Hold on Cadisegliatin Program

    17 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/17/3043683/0/en/vTv-Therapeutics-Announces-FDA-has-Lifted-Clinical-Hold-on-Cadisegliatin-Program-for-Diabetes.html

    GLOBENEWSWIRE
    17 Mar 2025
    Share Share
    vTv Announces FDA Submission for First Phase 3 Study of Cadisegliatin
    vTv Announces FDA Submission for First Phase 3 Study of Cadisegliatin

    04 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/03/04/2839535/0/en/vTv-Therapeutics-Announces-FDA-Submission-for-First-Phase-3-Study-of-Cadisegliatin-in-Patients-with-Type-1-Diabetes.html

    GLOBENEWSWIRE
    04 Mar 2024
    Share Share